Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

NEURODEGENERATIVE DISEASE

Genetic risk factors and role of immune dysfunction in FTLD

A new study has identified novel genes involved in sporadic frontotemporal lobar degeneration with neuronal inclusions of TAR DNA-binding protein 43. These findings might enable the elucidation of pathogenic mechanisms of the disease and have implications for the identification of potential therapeutic targets.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Pottier, C. et al. Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD. Acta Neuropathol. https://doi.org/10.1007/s00401-019-01962-9 (2019).

    Article  PubMed  Google Scholar 

  2. Lee, E. B. et al. Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration. Acta Neuropathol. 134, 65–78 (2017).

    Article  CAS  Google Scholar 

  3. Fenoglio, C. et al. Role of genetics and epigenetics in the pathogenesis of Alzheimer’s disease and frontotemporal dementia. J. Alzheimers Dis. 62, 913–932 (2018).

    Article  CAS  Google Scholar 

  4. Bang, J., Spina, S. & Miller, B. L. Frontotemporal dementia. Lancet 386, 1672–1682 (2015).

    Article  Google Scholar 

  5. Placek, K. et al. UNC3A polymorphism contributes to frontotemporal disease in sporadic amyotrophic lateral sclerosis. Neurobiol. Aging 73, 190–199 (2018).

    Article  Google Scholar 

  6. Galimberti, D. et al. Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study. Neurobiol. Aging 62, 245.e9–245.e12 (2018).

    Article  CAS  Google Scholar 

  7. McCauley, M. E. & Baloh, R. H. Inflammation in ALS/FTD pathogenesis. Acta Neuropathol. https://doi.org/10.1007/s00401-018-1933-9 (2019).

    Article  PubMed  Google Scholar 

  8. Haukedal, H. & Freude, K. Implications of microglia in amyotrophic lateral sclerosis and frontotemporal dementia. J. Mol. Biol. https://doi.org/10.1016/j.jmb.2019.02.004 (2019).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniela Galimberti.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Galimberti, D. Genetic risk factors and role of immune dysfunction in FTLD. Nat Rev Neurol 15, 250–251 (2019). https://doi.org/10.1038/s41582-019-0173-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41582-019-0173-5

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing